BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33181169)

  • 1. Transcutaneous application of the gaseous CO
    Finžgar M; Frangež HB; Cankar K; Frangež I
    Microvasc Res; 2021 Jan; 133():104100. PubMed ID: 33181169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transcutaneous application of gaseous carbon dioxide on cutaneous microcirculation.
    Finzgar M; Melik Z; Cankar K
    Clin Hemorheol Microcirc; 2015; 60(4):423-35. PubMed ID: 25261433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study.
    Rathsman B; Jensen-Urstad K; Nyström T
    Diabetologia; 2014 Aug; 57(8):1703-10. PubMed ID: 24802206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel--a placebo-controlled, randomized study.
    Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M
    Angiology; 2001 Dec; 52 Suppl 3():S35-41. PubMed ID: 11775647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous iontophoresis of treprostinil, a prostacyclin analog, increases microvascular blood flux in diabetic malleolus area.
    Hellmann M; Roustit M; Gaillard-Bigot F; Cracowski JL
    Eur J Pharmacol; 2015 Jul; 758():123-8. PubMed ID: 25843412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-occlusive reactive hyperaemia of skin microvasculature and foot complications in type 2 diabetes.
    Lanting SM; Barwick AL; Twigg SM; Johnson NA; Baker MK; Chiu SK; Caterson ID; Chuter VH
    J Diabetes Complications; 2017 Aug; 31(8):1305-1310. PubMed ID: 28545894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of transcutaneous application of gaseous CO
    Macura M; Ban Frangez H; Cankar K; Finžgar M; Frangez I
    Int Wound J; 2020 Dec; 17(6):1607-1614. PubMed ID: 32633896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CO2-induced acral blood flow and the oxygen partial pressure in arterial occlusive disease].
    Hartmann B; Drews B; Bassenge E
    Dtsch Med Wochenschr; 1991 Oct; 116(43):1617-21. PubMed ID: 1935632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in skin blood flow oscillations between the plantar and dorsal foot in people with diabetes mellitus and peripheral neuropathy.
    Jan YK; Liao F; Cheing GLY; Pu F; Ren W; Choi HMC
    Microvasc Res; 2019 Mar; 122():45-51. PubMed ID: 30414870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glibenclamide on cutaneous laser-Doppler flux.
    Cankar K; Strucl M
    Microvasc Res; 2008 Jan; 75(1):97-103. PubMed ID: 17675187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectral analysis of the blood flow in the foot microvascular bed during thermal testing in patients with diabetes mellitus.
    Mizeva I; Zharkikh E; Dremin V; Zherebtsov E; Makovik I; Potapova E; Dunaev A
    Microvasc Res; 2018 Nov; 120():13-20. PubMed ID: 29802880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why critical limb ischemia criteria are not applicable to diabetic foot and what the consequences are.
    Jörneskog G
    Scand J Surg; 2012; 101(2):114-8. PubMed ID: 22623444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy--a placebo-controlled, randomized study.
    Cesarone MR; Incandela L; Belcaro G; De Sanctis MT; Ricci A; Griffin M
    Angiology; 2001 Dec; 52 Suppl 3():S43-8. PubMed ID: 11775648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired microvascular flow motion in subclinical diabetic feet with sudomotor dysfunction.
    Sun PC; Chen CS; Kuo CD; Lin HD; Chan RC; Kao MJ; Wei SH
    Microvasc Res; 2012 Mar; 83(2):243-8. PubMed ID: 21722653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carbon dioxide-enriched water and fresh water on the cutaneous microcirculation and oxygen tension in the skin of the foot.
    Hartmann BR; Bassenge E; Pittler M
    Angiology; 1997 Apr; 48(4):337-43. PubMed ID: 9112881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization.
    Arora S; Pomposelli F; LoGerfo FW; Veves A
    J Vasc Surg; 2002 Mar; 35(3):501-5. PubMed ID: 11877698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process.
    Araszkiewicz A; Soska J; Borucka K; Olszewska M; Niedzwiecki P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2015 Sep; 101():143-7. PubMed ID: 26239695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients.
    Jörneskog G; Brismar K; Fagrell B
    Vasa; 1993; 22(2):137-42. PubMed ID: 8391741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.